TLR-mediated activation of NK cells and their role in bacterial/viral immune responses in mammals

Immunology and Cell Biology

Volumn 92, Issue 3, 2014, Pages 256-262

  Adib Conquy, Minou ^a   Scott Algara, Daniel ^a   Cavaillon, Jean Marc ^a   Souza Fonseca Guimaraes, Fernando ^b  

^a INSTITUT PASTEUR   (France)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

bacterial and viral sensing; IFN g; NK cell; TLR

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 18; TOLL LIKE RECEPTOR;

ACCESSORY CELL; AGONIST; BACTERIAL INFECTION; BACTERIUM; CYTOKINE PRODUCTION; DENDRITIC CELL; IMMUNE RESPONSE; INNATE IMMUNITY; LYMPHOCYTE ACTIVATION; MACROPHAGE; MONOCYTE; NATURAL KILLER CELL; NONHUMAN; PROTEIN EXPRESSION; REVIEW; VIRUS; VIRUS INFECTION;

BACTERIA (MICROORGANISMS); MAMMALIA;

ANIMALS; BACTERIA; HUMANS; IMMUNITY; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MAMMALS; TOLL-LIKE RECEPTORS; VIRUSES;

EID: 84898972548     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2013.99     Document Type: Review

References (100)

1. Kapetanovic R, Cavaillon JM. Early events in innate immunity in the recognition of microbial pathogens. Expert Opin Biol Ther 2007; 7: 907-918.
2. Adib-Conquy M, Cavaillon JM. Stress molecules in sepsis and systemic inflammatory response syndrome. Febs Lett 2007; 581: 3723-3733.
3. Lee CC, Avalos AM, Ploegh HL. Accessory molecules for Toll-like receptors and their function. Nat Rev Immunol 2012; 12: 168-179.
4. O'Neill LA, Golenbock D, Bowie AG. The history of Toll-like receptors-redefining innate immunity. Nat Rev Immunol 2013; 13: 453-460.
5. Hornef MW, Normark BH, Vandewalle A, Normark S. Intracellular recognition of lipopolysaccharide by Toll-like receptor 4 in intestinal epithelial cells. J Exp Med 2003; 198: 1225-1235.
6. Uronen-Hansson H, Allen J, Osman M, Squires G, Klein N, Callard RE. Toll-like receptor 2 (TLR2) and TLR4 are present inside human dendritic cells, associated with microtubules and the Golgi apparatus but are not detectable on the cell surface: integrity of microtubules is required for interleukin-12 production in response to internalized bacteria. Immunology 2004; 111: 173-178.
7. Shuang C, Wong MH, Schulte DJ, Arditi M, Michelsen KS. Differential expression of Toll-like receptor 2 (TLR2) and responses to TLR2 ligands between human and murine vascular endothelial cells. J Endotox Res 2007; 13: 281-296.
8. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006; 124: 783-801.
9. Martinon F, Tschopp J. NLRs join TLRs as innate sensors of pathogens. Trends Immunol 2005; 26: 447-454.
10. Kiessling R, Klein E, Pross H, Wigzell H. 'Natural' killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell. Eur J Immunol 1975; 5: 117-121.
11. Pross HF, Jondal M. Cytotoxic lymphocytes from normal donors. A functional marker of human non-T lymphocytes. Clin Exp Immunol 1975; 21: 226-235.
12. Macfarlan RI, Burns WH, White DO. Two cytotoxic cells in peritoneal cavity of virusinfected mice: antibody-dependent macrophages and nonspecific killer cells. J Immunol 1977; 119: 1569-1574.
13. Tagliabue A, Nencioni L, Villa L, Boraschi D. Genetic control of in vitro natural cellmediated activity against Salmonella typhimurium by intestinal and splenic lymphoid cells in mice. Clin Exp Immunol 1984; 56: 531-536.
14. Souza-Fonseca-Guimaraes F, Adib-Conquy M, Cavaillon JM. Natural killer (NK) cells in antibacterial innate immunity: angels or devils? Mol Med 2012; 18: 270-285.
15. Souza-Fonseca-Guimaraes F, Cavaillon JM, Adib-Conquy M. Bench-to-bedside review: natural killer cells in sepsis-guilty or not guilty? Crit Care 2013; 17: 235.
16. Beutler B, Eidenschenk C, Crozat K, Imler JL, Takeuchi O, Hoffmann JA et al. Genetic analysis of resistance to viral infection. Nat Rev Immunol 2007; 7: 753-766.
17. Lauzon NM, Mian F, MacKenzie R, Ashkar AA. The direct effects of Toll-like receptor ligands on human NK cell cytokine production and cytotoxicity. Cell Immunol 2006; 241: 102-112.
18. Chalifour A, Jeannin P, Gauchat JF, Blaecke A, Malissard M, N'Guyen T et al. Direct bacterial protein PAMP recognition by human NK cells involves TLRs and triggers alpha-defensin production. Blood 2004; 104: 1778-1783.
19. Saikh KU, Lee JS, Kissner TL, Dyas B, Ulrich RG. Toll-like receptor and cytokine expression patterns of CD56\+ T cells are similar to natural killer cells in response to infection with Venezuelan equine encephalitis virus replicons. J Infect Dis 2003; 188: 1562-1570.
20. Gorski KS, Waller EL, Bjornton-Severson J, Hanten JA, Riter CL, Kieper WC et al. Distinct indirect pathways govern human NK-cell activation by TLR-7 and TLR-8 agonists. Int Immunol 2006; 18: 1115-1126.
21. Alter G, Suscovich TJ, Teigen N, Meier A, Streeck H, Brander C et al. derived from HIV-1 serves as a potent activator of NK cells. J Immunol 2007; 178: 7658-7666.
22. Sawaki J, Tsutsui H, Hayashi N, Yasuda K, Akira S, Tanizawa T et al. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways. Int Immunol 2007; 19: 311-320.
23. Martinez J, Huang XP, Yang YP. Direct TLR2 Signaling Is Critical for NK Cell Activation and Function in Response to Vaccinia Viral Infection. PLoS Pathog 2010; 6: 3.
24. Flo TH, Halaas O, Torp S, Ryan L, Lien E, Dybdahl B et al. Differential expression of Toll-like receptor 2 in human cells. J Leukoc Biol 2001; 69: 474-481.
25. Becker I, Salaiza N, Aguirre M, Delgado J, Carrillo-Carrasco N, Kobeh LG et al. Leishmania lipophosphoglycan (LPG) activates NK cells through toll-like receptor-2. Mol Biochem Parasitol 2003; 130: 65-74.
26. Eriksson M, Meadows SK, Basu S, Mselle TF, Wira CR, Sentman CL. TLRs mediate IFN-gamma production by human uterine NK cells in endometrium. J Immunol 2006; 176: 6219-6224.
27. Comin F, Speziali E, Martins-Filho OA, Caldas IR, Moura V, Gazzinelli A et al. Ageing and Toll-like receptor expression by innate immune cells in chronic human schistosomiasis. Clin Exp Immunol 2007; 149: 274-284.
28. Tadema H, Abdulahad WH, Stegeman CA, Kallenberg CG, Heeringa P. Increased expression of Toll-like receptors by monocytes and natural killer cells in ANCAassociated vasculitis. PLoS One 2011; 2011: 9.
29. Souza-Fonseca-Guimaraes F, Parlato M, Philippart F, Misset B, Cavaillon JM, Adib-Conquy MStudy Group C. Toll-like receptors expression and interferon-gamma production by NK cells in human sepsis. Crit Care 2012; 16: R206.
30. Souza-Fonseca-Guimaraes F, Parlato M, Fitting C, Cavaillon JM, Adib-Conquy M. NK. Cell Tolerance to TLR Agonists Mediated by Regulatory T Cells after Polymicrobial Sepsis. J Immunol 2012; 188: 5850-5858.
31. Qiu F, Maniar A, Quevedo Diaz M, Chapoval AI, Medvedev AE. Activation of cytokineproducing and antitumor activities of natural killer cells and macrophages by engagement of Toll-like and NOD-like receptors. Innate Immun 2011; 17: 375-387.
32. Athie-Morales V, O'Connor GM, Gardiner CM. Activation of human NK cells by the bacterial pathogen-associated molecular pattern muramyl dipeptide. J Immunol 2008; 180: 4082-4089.
33. Perrot I, Deauvieau F, Massacrier C, Hughes N, Garrone P, Durand I et al. TLR3 and Rig-like receptor on myeloid dendritic cells and Rig-like receptor on human NK cells are both mandatory for production of IFN-gamma in response to double-stranded RNA. J Immunol 2010; 185: 2080-2088.
34. Tsujimoto H, Uchida T, Efron PA, Scumia PO, Verma A, Matsumoto T et al. Flagellin enhances NK cell proliferation and, activation directly and through dendritic cell-NK cell interactions. J Leukoc Biol 2005; 78: 888-897.
35. Golden-Mason L, Stone AE, Bambha KM, Cheng L, Rosen HR. Race-and genderrelated variation in natural killer p46 expression associated with differential antihepatitis C virus immunity. Hepatology 2012; 56: 2349-2358.
36. Hornung V, Rothenfusser S, Britsch S, Krug A, Jahrsdorfer B, Giese T et al. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol 2002; 168: 4531-4537.
37. Gregoire C, Chasson L, Luci C, Tomasello E, Geissmann F, Vivier E et al. The trafficking of natural killer cells. Immunol Rev 2007; 220: 169-182.
38. Girart MV, Fuertes MB, Domaica CI, Rossi LE, Zwirner NW. Engagement of TLR3, TLR7, and NKG2D regulate IFN-gamma secretion but not NKG2D-Mediated cytotoxicity by human NK cells stimulated with suboptimal doses of IL-12. J Immunol 2007; 179: 3472-3479.
39. Millard AL, Spirig R, Mueller NJ, Seebach JD, Rieben R. Inhibition of direct and indirect TLR-mediated activation of human NK cells by low molecular weight dextran sulfate. Mol Immunol 2010; 47: 2349-2358.
40. Ebihara T, Azuma M, Oshiumi H, Kasamatsu J, Iwabuchi K, Matsumoto K et al. Identification of a polyI:C-inducible membrane protein that participates in dendritic cell-mediated natural killer cell activation. J Exp Med 2010; 207: 2675-2687.
41. Esin S, Counoupas C, Aulicino A, Brancatisano FL, Maisetta G, Bottai D et al. Interaction of Mycobacterium tuberculosis cell wall components with the human natural killer cell receptors NKp44 and Toll-like receptor 2. Scand J Immunol 2013; 77: 460-469.
42. Mian MF, Lauzon NM, Andrews DW, Lichty BD, Ashkar AA. FimH can directly activate human and murine natural killer cells via TLR4. Mol Ther 2010; 18: 1379-1388.
43. Shimazu R, Akashi S, Ogata H, Nagai Y, Fukudome K, Miyake K et al. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J Exp Med 1999; 189: 1777-1782.
44. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H et al. A Toll-like receptor recognizes bacterial DNA (vol 408, pg 740, 2000). Nature 2001; 409: 646-U22.
45. Chockalingam A, Brooks JC, Cameron JL, Blim LK, Leifer CA. TLR9 traffics through the Golgi complex to localize to endolysosomes and respond to CpG DNA. Immunol Cell Biol 2009; 87: 209-217.
46. Souza-Fonseca-Guimaraes F, Parlato Mariana, de Oliveira RB, Golenbock D, Fitzgerald K, Shalova IN et al. Interferon-gamma and granulocyte/monocyte colonystimulating factor production by natural killer cells involves different signaling pathways and the adaptor stimulator of interferon genes (STING). J Biol Chem 2013; 288: 10715-10721.
47. Chenoweth MJ, Mian MF, Barra NG, Alain T, Sonenberg N, Bramson J et al. IL-15 Can Signal via IL-15R alpha, JNK, and NF-kappa B To Drive RANTES Production by Myeloid Cells. J Immunol 2012; 188: 4149-4157.
48. Ishikawa H, Ma Z, Barber GN. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature 2009; 461: 788-U40.
49. Leifer CA, Kennedy MN, Mazzoni A, Lee CW, Kruhlak MJ, Segal DA. TLR9 Is localized in the endoplasmic reticulum prior to stimulation. J Immunol 2004; 173: 1179-1183.
50. Kim YM, Brinkmann MM, Paquet ME, Ploegh HL. UNC93B1 delivers nucleotidesensing toll-like receptors to endolysosomes. Nature 2008; 452: 234-U80.
51. Engel A, Barton GM. Compartment-specific control of signaling from a DNA-sensing immune receptor. Sci Signal 2010; 3: pe45.
52. Sivori S, Carlomagno S, Moretta L, Moretta A. Comparison of different CpG oligodeoxynucleotide classes for their capability to stimulate human NK cells. Eur J Immunol 2006; 36: 961-967.
53. Lewis L. Evolutionary struggles between NK cells and viruses. Nat Rev Immunol 2008; 8: 259-268.
54. Pisegna S, Pirozzi G, Piccoli M, Frati L, Santoni A, Palmieri G. p38 MAPK activation controls the TLR3-mediated up-regulation of cytotoxicity and cytokine production in human NK cells. Blood 2004; 104: 4157-4164.
55. Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar-Mather TP. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol 1999; 17: 189-220.
56. Kim M, Osborne NR, Zeng WG, Donaghy H, McKinnon K, Jackson DC et al. Herpes simplex virus antigens directly activate NK cells via TLR2, thus facilitating their presentation to CD4 T lymphocytes. J Immunol 2012; 188: 4158-4170.
57. Szomolanyi-Tsuda E, Liang XY, Welsh RM, Kurt-Jones EA, Finberg RW. Role for TLR2 in NK cell-mediated control of murine cytomegalovirus in vivo. J Virol 2006; 80: 4286-4291.
58. Kaisho T. Pathogen sensors and chemokine receptors in dendritic cell subsets. Vaccine 2012; 30: 7652-7657.
59. Hart OM, Athie-Morales V, O'Connor GM, Gardiner CM. TLR7/8-mediated activation of human NK cells results in accessory cell-dependent IFN-gamma production. J Immunol 2005; 175: 1636-1642.
60. Hertzog PJ, O'Neill LA, Hamilton JA. The interferon in TLR signaling: more than just antiviral. Trends Immunol 2003; 24: 534-539.
61. Sivori S, Falco M, Della Chiesa M, Carlomagno S, Vitale M, Moretta L et al. CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells. Proc Natl Acad Sci USA 2004; 101: 10116-10121.
62. Stephenson RM, Lim C, Matthews M, Dietsch G, Hershberg R, Ferris RL. TLR8 stimulation enhances cetuximab-mediated natural killer cell lysis of head and neck cancer cells and dendritic cell cross-priming of EGFR-specific CD8\+ T cells. Cancer Immunol Immunother 2013; 62: 1347-1357.
63. Lu H, Dietsch G, Matthews MA, Yang Y, Ghanekar S, Inokuma M et al. VTX-2337 is a novel TLR8 agonist that activates NK cells and augments ADCC. Clin Cancer Res 2012; 18: 499-509.
64. Eljaafari FM, Takada H, Tanaka T, Doi T, Ohga S, Hara T. Potent induction of IFN-g production from cord blood NK cells by the stimulation with single-stranded RNA. J Clin Immunol 2011; 31: 728-735.
65. Endt J, Eissmann P, Hoffmann SC, Meinke S, Giese T, Watzl C. Modulation of 2B4 (CD244) activity and regulated SAP expression in human NK cells. Eur J Immunol 2007; 37: 193-198.
66. Huntington ND, Vosshenrich CAJ, Di Santo JP. Developmental pathways that generate natural-killer-cell diversity in mice and humans. Nat Rev Immunol 2007; 7: 703-714.
67. Seki S, Osada S, Ono S, Aosasa S, Habu Y, Nishikage T et al. Role of liver NK cells and peritoneal macrophages in gamma interferon and interleukin-10 production in experimental bacterial peritonitis in mice. Infect Immun 1998; 66: 5286-5294.
68. Blanchard DK, Stewart WE 2nd, Klein TW, Friedman H, Djeu JY. Cytolytic activity of human peripheral blood leukocytes against Legionella pneumophila-infected monocytes: characterization of the effector cell and augmentation by interleukin 2. J Immunol 1987; 139: 551-556.
69. Katz P, Yeager H Jr., Whalen G, Evans M, Swartz RP, Roecklein J. Natural killer cellmediated lysis of Mycobacterium-avium complex-infected monocytes. J Clin Immunol 1990; 10: 71-77.
70. Harshan KV, Gangadharam PR. In vivo depletion of natural killer cell activity leads to enhanced multiplication of Mycobacterium avium complex in mice. Infect Immun 1991; 59: 2818-2821.
71. Lopez MC, Duckett NS, Baron SD, Metzger DW. Early activation of NK cells after lung infection with the intracellular bacterium, Francisella tularensis LVS. Cell Immunol 2004; 232: 75-85.
72. Teixeira HC, Kaufmann SH. Role of NK1.1\+ cells in experimental listeriosis. NK1\+ cells are early IFN-gamma producers but impair resistance to Listeria monocytogenes infection. J Immunol 1994; 152: 1873-1882.
73. Thäle C, Kiderlen AF. Sources of interferon-gamma (IFN-gamma) in early immune response to Listeria monocytogenes. Immunobiology 2005; 210: 673-683.
74. Rottenberg ME, Rothfuchs AG, Gigliotti D, Ceausu M, Une C, Levitsky V et al. Regulation and role of IFN-gamma in the innate resistance to infection with Chlamydia pneumoniae. J Immunol 2000; 164: 4812-4818.
75. Bohn E, Autenrieth IB. IL-12 is essential for resistance against Yersinia enterocolitica by triggering IFN-gamma production in NK cells and CD4\+ Tcells. J Immunol 1996; 156: 1458-1468.
76. Emoto M, Miyamoto M, Yoshizawa I, Emoto Y, Schaible UE, Kita E et al. Critical role of NK cells rather than V alpha 14(\+)NKT cells in lipopolysaccharide-induced lethal shock in mice. J Immunol 2002; 169: 1426-1432.
77. Etogo AO, Nunez J, Lin CY, Toliver-Kinsky TE, Sherwood ER. NK but not CD1-restricted NKT cells facilitate systemic inflammation during polymicrobial intraabdominal sepsis. J Immunol 2008; 180: 6334-6345.
78. Nakano Y, Onozuka K, Terada Y, Shinomiya H, Nakano M. Protective effect of recombinant tumor necrosis factor-alpha in murine salmonellosis. J Immunol 1990; 144: 1935-1941.
79. Mancuso G, Midiri A, Biondo C, Beninati C, Zummo S, Galbo R et al. Type I IFN signaling is crucial for host resistance against different species of pathogenic bacteria. J Immunol 2007; 178: 3126-3133.
80. Zantl N, Uebe A, Neumann B, Wagner H, Siewert JR, Holzmann B et al. Essential role of gamma interferon in survival of colon ascendens stent peritonitis, a novel murine model of abdominal sepsis. Infect Immun 1998; 66: 2300-2309.
81. Scott MJ, Hoth JJ, Gardner SA, Peyton JC, Cheadle WG. Natural killer cell activation primes macrophages to clear bacterial infection. Am Surg 2003; 69: 679-686; discussion 686-7.
82. Herzig DS, Driver BR, Fang GP, Toliver-Kinsky TE, Shute EN, Sherwood ER. Regulation of lymphocyte trafficking by CXC chemokine receptor 3 during septic shock. Am J Respir Crit Care Med 2012; 185: 291-300.
83. Chiossone L, Chaix J, Fuseri N, Roth C, Vivier E, Walzer T. Maturation of mouse NK cells is a 4-stage developmental program. Blood 2009; 113: 5488-5496.
84. Venet F, Davin F, Guignant C, Larue A, Cazalis MA, Darbon R et al. Early assessment of leukocyte alterations at diagnosis of septic shock. Shock 2010; 34: 358-363.
85. Giamarellos-Bourboulis EJ, Tsaganos T, Spyridaki E, Mouktaroudi M, Plachouras D, Vaki I et al. Early changes of CD4-positive lymphocytes and NK cells in patients with severe Gram-negative sepsis. Crit Care 2006; 10: 6.
86. Batoni G, Esin S, Favilli F, Pardini M, Bottai D, Maisetta G et al. Human CD56bright and CD56dim natural killer cell subsets respond differentially to direct stimulation with Mycobacterium bovis bacillus Calmette-Guerin. Scand J Immunol 2005; 62: 498-506.
87. Newman KC, Riley EM. Whatever turns you on: accessory-cell-dependent activation of NK cells by pathogens. Nat Rev Immunol 2007; 7: 279-291.
88. Lucas M, Schachterle W, Oberle K, Aichele P, Diefenbach A. Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity 2007; 26: 503-517.
89. Scott MJ, Hoth JJ, Stagner MK, Gardner SA, Peyton JC, Cheadle WG. CD40-CD154 interactions between macrophages and natural killer cells during sepsis are critical for macrophage activation and are not interferon gamma dependent. Clin Exp Immunol 2004; 137: 469-477.
90. Lapaque N, Walzer T, Meresse S, Vivier E, Trowsdale J. Interactions between human NK cells and macrophages in response to Salmonella infection. J Immunol 2009; 182: 4339-4348.
91. Godshall CJ, Scott MJ, Burch PT, Peyton JC, Cheadle WG. Natural killer cells participate in bacterial clearance during septic peritonitis through interactions with macrophages. Shock 2003; 19: 144-149.
92. Hamerman JA, Ogasawara K, Lanier LL. Cutting edge: Toll-like receptor signaling in macrophages induces ligands for the NKG2D receptor. J Immunol 2004; 172: 2001-2005.
93. Kloss M, Decker P, Baltz KM, Baessler T, Jung G, Rammensee HG et al. Interaction of monocytes with NK cells upon Toll-like receptor-induced expression of the NKG2D ligand MICA. J Immunol 2008; 181: 6711-6719.
94. Borchers MT, Harris NL, Wesselkamper SC, Zhang S, Chen Y, Young L et al. The NKG2D-activating receptor mediates pulmonary clearance of Pseudomonas aeruginosa. Infect Immun 2006; 74: 2578-2586.
95. Badgwell B, Parihar R, Magro C, Dierksheide J, Russo T, Carson WE. Natural killer cells contribute to the lethality of a murine model of Escherichia coli infection. Surgery 2002; 132: 205-212.
96. Goldmann O, Chhatwal GS, Medina E. Contribution of natural killer cells to the pathogenesis of septic shock induced by Streptococcus pyogenes in mice. J Infect Dis 2005; 191: 1280-1286.
97. Andaluz-Ojeda D, Iglesias V, Bobillo F, Almansa R, Rico L, Gandia F et al. Early natural killer cell counts in blood predict mortality in severe sepsis. Crit Care 2011; 15: R243.
98. Kurt-Jones EA, Chan M, Zhou S, Wang J, Reed G, Bronson R et al. Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc Natl Acad Sci USA 2004; 101: 1315-1320.
99. Wang T, Town T, Alexopoulou L, Anderson JF, Fikrig E, Flavell RA. Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat Med 2004; 10: 1366-1373.
100. Krug A, French AR, Barchet W, Fischer JA, Dzionek A, Pingel JT et al. TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. Immunity 2004; 21: 107-119.